Cefixime Capsules 400 mg — Class II drug recall D-0229-2022
Terminated recall by Ascend Laboratories LLC, reported 2021-11-17, distributed nationwide. Failed Impurities/Degradation Specifications
| Recall number | D-0229-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Ascend Laboratories LLC, Parsippany, NJ, United States |
| Recall initiated | 2021-11-03 |
| Classified | 2021-11-09 |
| Reported by FDA | 2021-11-17 |
| Terminated | 2022-12-21 |
| Distributed | Nationwide (US) |
| Quantity | 4,104 bottles |
| Reason classes | specification failure |
| NDC | 67877-0584, 67877-0584-01, 67877-0584-05, 67877-0584-33, 67877-0584-50 |
| Lot numbers | 20140282 |
| Expiration dates | 2021-12-20 |
Product
Cefixime Capsules 400 mg, 50 capsules bottles, Rx Only, Manufactured by: Alken Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories LLC, Parsippany, NJ, 07054 NDC 67877-584-50
Reason for recall
Failed Impurities/Degradation Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0229-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.